These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 8457839)

  • 1. Altered dopamine receptor mediated signal transmission in the striatum of aged rats.
    May T; Sugawa M
    Brain Res; 1993 Feb; 604(1-2):106-11. PubMed ID: 8457839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic desipramine treatment influences D1 stimulation and D2 inhibition (dual control) of adenylate cyclase by dopamine in rat striatum.
    Okada F; Horikawa T; Tokumitsu Y; Nomura Y
    Neurochem Int; 1994 Jan; 24(1):23-7. PubMed ID: 8130732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ; Marshall JF
    Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
    Makman MH; Dvorkin B
    Brain Res; 1986 Dec; 387(3):261-70. PubMed ID: 2950967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of desipramine during infancy and preweanling on dorsal striatal dopamine D1 and D2 receptor binding in adolescence in the rat.
    Hilakivi I; Rinne J; Marjamäki P
    Pol J Pharmacol; 1999; 51(4):311-6. PubMed ID: 10540962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Striatal dopamine D1-like receptors have higher affinity for dopamine in ethanol-treated rats.
    May T
    Eur J Pharmacol; 1992 May; 215(2-3):313-6. PubMed ID: 1396997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
    Urwyler S; Markstein R
    J Neurochem; 1986 Apr; 46(4):1058-67. PubMed ID: 2936868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chimeric D1/D2 dopamine receptors. Distinct determinants of selective efficacy, potency, and signal transduction.
    Kozell LB; Machida CA; Neve RL; Neve KA
    J Biol Chem; 1994 Dec; 269(48):30299-306. PubMed ID: 7982941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GTP regulation of (-)-stepholidine binding to R(H) of D1 dopamine receptors in calf striatum.
    Dong ZJ; Chen LJ; Jin GZ; Creese I
    Biochem Pharmacol; 1997 Jul; 54(2):227-32. PubMed ID: 9271326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signal transduction interactions between CB1 cannabinoid and dopamine receptors in the rat and monkey striatum.
    Meschler JP; Howlett AC
    Neuropharmacology; 2001 Jun; 40(7):918-26. PubMed ID: 11378162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine D1 and D2 receptors and their signal system present in coated vesicles prepared from bovine striatal tissue.
    Ozaki N; Moroi K; Kadota T; Suzuki S; Kadota K
    J Neurochem; 1994 Feb; 62(2):582-91. PubMed ID: 8294921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological characterization of the D1- and D2-like dopamine receptors from the brain of the leopard frog, Rana pipiens.
    Chu J; Wilczynski W; Wilcox RE
    Brain Behav Evol; 2001 Jun; 57(6):328-42. PubMed ID: 11713387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptive mechanisms of striatal D1 and D2 dopamine receptors in response to a prolonged reserpine treatment in mice.
    Rubinstein M; Muschietti JP; Gershanik O; Flawia MM; Stefano FJ
    J Pharmacol Exp Ther; 1990 Feb; 252(2):810-6. PubMed ID: 2138223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental and age-related changes in D1-dopamine receptors and dopamine content in the rat striatum.
    Giorgi O; De Montis G; Porceddu ML; Mele S; Calderini G; Toffano G; Biggio G
    Brain Res; 1987 Oct; 432(2):283-90. PubMed ID: 2960426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postnatal development of dopamine D1-like and D2-like receptors in the rat kidney: a radioligand binding study.
    Tenore G; Barili P; Sabbatini M; Tayebati SK; Amenta F
    Mech Ageing Dev; 1997 Apr; 95(1-2):1-11. PubMed ID: 9152957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D2 receptor antagonists do not modify guanine nucleotide-sensitive interactions between dopamine and D1 dopamine receptors under in vitro conditions.
    Farrell CB; Lawlor M; Dunne A; O'Boyle KM
    J Neurochem; 1995 Sep; 65(3):1124-30. PubMed ID: 7643090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characterization and autoradiographic localization of dopamine receptors in the rat adrenal medulla.
    Barili P; Zaccheo D; Amenta F
    Eur J Pharmacol; 1996 Aug; 310(2-3):129-35. PubMed ID: 8884208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ceruletide on perioral movements and the dopamine receptor-adenylate cyclase system in rats chronically treated with fluphenazine.
    Ashizawa T; Saito T; Takahata N
    Psychopharmacology (Berl); 1996 Jun; 125(3):185-94. PubMed ID: 8815952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation by GTP of basal and agonist-stimulated striatal adenylate cyclase activity following chronic blockade of D1 and D2 dopamine receptors: involvement of G proteins in the development of receptor supersensitivity.
    Schettini G; Ventra C; Florio T; Grimaldi M; Meucci O; Marino A
    J Neurochem; 1992 Nov; 59(5):1667-74. PubMed ID: 1402912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the bovine striatal D2 receptor, but not the D1 receptor, in bovine adrenal medulla.
    Maroto R; López MG; del Valle M; Naranjo JR; Mellström B; García AG
    Mol Pharmacol; 1995 Jan; 47(1):40-50. PubMed ID: 7838132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.